Discover recent advancements in oncology including FDA accelerated approval for Nogapendekin Alfa Combo in NMIBC type and fast track designation…
Month: January 2026
Latest Developments in Oncology: T-DXD/Pertuzumab, SRN-101, KTX-1001, Proton Therapy, and PSMA PET
Discover the latest advancements in cancer treatment focusing on T-DXD/Pertuzumabs Type II Application Validation, FDA Fast Track Designation for SRN-101,…